Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3357622
Max Phase: Preclinical
Molecular Formula: C19H24BrN3O6
Molecular Weight: 470.32
Molecule Type: Small molecule
Associated Items:
ID: ALA3357622
Max Phase: Preclinical
Molecular Formula: C19H24BrN3O6
Molecular Weight: 470.32
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cccc(COC(=O)N2CCC[C@H]2C(=O)NC[C@@H]2CC(Br)=NO2)c1OC
Standard InChI: InChI=1S/C19H24BrN3O6/c1-26-15-7-3-5-12(17(15)27-2)11-28-19(25)23-8-4-6-14(23)18(24)21-10-13-9-16(20)22-29-13/h3,5,7,13-14H,4,6,8-11H2,1-2H3,(H,21,24)/t13-,14-/m0/s1
Standard InChI Key: FQZHHQVIEFGUIH-KBPBESRZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 470.32 | Molecular Weight (Monoisotopic): 469.0848 | AlogP: 2.42 | #Rotatable Bonds: 7 |
Polar Surface Area: 98.69 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 1.63 | CX LogD: 1.63 |
Aromatic Rings: 1 | Heavy Atoms: 29 | QED Weighted: 0.66 | Np Likeness Score: -0.84 |
1. Klöck C, Herrera Z, Albertelli M, Khosla C.. (2014) Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2., 57 (21): [PMID:25333388] [10.1021/jm501145a] |
Source(1):